OliX says its expansion will include the construction of an RNA synthesis GMP manufacturing facility at its San Diego site, which will initially carry out oligonucleotide chemistry and analysis for investigational therapeutics to be developed in-house for clinical testing, with the potential to manufacture commercial RNAi therapeutics there . . .

Get GEN Edge Today!

The post OliX Advancing in Nucleic Acid Therapeutics appeared first on GEN – Genetic Engineering and Biotechnology News.

Source